Irritable Bowel Syndrome-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data

Number Of Pages: 146
Publisher Name: Market Informing
Published date: Aug 01 2019
sms Speak to Analyst
help_outlineEnquiry before buying
file_download Sample Request
new_releases Request Discount

Report Summary

Irritable Bowel Syndrome-Global Market Status & Trend Report 2014-2026 Top 20 Countries Data offers a comprehensive analysis on Irritable Bowel Syndrome industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Top 20 Countries Market Size of Irritable Bowel Syndrome 2014-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Irritable Bowel Syndrome worldwide and market share by regions, with company and product introduction, position in the Irritable Bowel Syndrome market
Market status and development trend of Irritable Bowel Syndrome by types and applications
Cost and profit status of Irritable Bowel Syndrome, and marketing status
Market growth drivers and challenges

The report segments the global Irritable Bowel Syndrome market as:

Global Irritable Bowel Syndrome Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2014-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Irritable Bowel Syndrome Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2014-2026):
IBS-D Drug
IBS-C Drug
Others

Global Irritable Bowel Syndrome Market: Application Segment Analysis (Consumption Volume and Market Share 2014-2026; Downstream Customers and Market Analysis)
Women
Men

Global Irritable Bowel Syndrome Market: Manufacturers Segment Analysis (Company and Product introduction, Irritable Bowel Syndrome Sales Volume, Revenue, Price and Gross Margin):
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
Chapter 1 Overview of Irritable Bowel Syndrome
1.1 Definition of Irritable Bowel Syndrome in This Report
1.2 Commercial Types of Irritable Bowel Syndrome
1.2.1 IBS-D Drug
1.2.2 IBS-C Drug
1.2.3 Others
1.3 Downstream Application of Irritable Bowel Syndrome
1.3.1 Women
1.3.2 Men
1.4 Development History of Irritable Bowel Syndrome
1.5 Market Status and Trend of Irritable Bowel Syndrome 2014-2026
1.5.1 Global Irritable Bowel Syndrome Market Status and Trend 2014-2026
1.5.2 Regional Irritable Bowel Syndrome Market Status and Trend 2014-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Irritable Bowel Syndrome 2014-2019
2.2 Sales Market of Irritable Bowel Syndrome by Regions
2.2.1 Sales Volume of Irritable Bowel Syndrome by Regions
2.2.2 Sales Value of Irritable Bowel Syndrome by Regions
2.3 Production Market of Irritable Bowel Syndrome by Regions
2.4 Global Market Forecast of Irritable Bowel Syndrome 2020-2026
2.4.1 Global Market Forecast of Irritable Bowel Syndrome 2020-2026
2.4.2 Market Forecast of Irritable Bowel Syndrome by Regions 2020-2026
Chapter 3 Global Market Status and Forecast by Types
3.1 Sales Volume of Irritable Bowel Syndrome by Types
3.2 Sales Value of Irritable Bowel Syndrome by Types
3.3 Market Forecast of Irritable Bowel Syndrome by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Global Sales Volume of Irritable Bowel Syndrome by Downstream Industry
4.2 Global Market Forecast of Irritable Bowel Syndrome by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
5.1 North America Irritable Bowel Syndrome Market Status by Countries
5.1.1 North America Irritable Bowel Syndrome Sales by Countries (2014-2019)
5.1.2 North America Irritable Bowel Syndrome Revenue by Countries (2014-2019)
5.1.3 United States Irritable Bowel Syndrome Market Status (2014-2019)
5.1.4 Canada Irritable Bowel Syndrome Market Status (2014-2019)
5.1.5 Mexico Irritable Bowel Syndrome Market Status (2014-2019)
5.2 North America Irritable Bowel Syndrome Market Status by Manufacturers
5.3 North America Irritable Bowel Syndrome Market Status by Type (2014-2019)
5.3.1 North America Irritable Bowel Syndrome Sales by Type (2014-2019)
5.3.2 North America Irritable Bowel Syndrome Revenue by Type (2014-2019)
5.4 North America Irritable Bowel Syndrome Market Status by Downstream Industry (2014-2019)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
6.1 Europe Irritable Bowel Syndrome Market Status by Countries
6.1.1 Europe Irritable Bowel Syndrome Sales by Countries (2014-2019)
6.1.2 Europe Irritable Bowel Syndrome Revenue by Countries (2014-2019)
6.1.3 Germany Irritable Bowel Syndrome Market Status (2014-2019)
6.1.4 UK Irritable Bowel Syndrome Market Status (2014-2019)
6.1.5 France Irritable Bowel Syndrome Market Status (2014-2019)
6.1.6 Italy Irritable Bowel Syndrome Market Status (2014-2019)
6.1.7 Russia Irritable Bowel Syndrome Market Status (2014-2019)
6.1.8 Spain Irritable Bowel Syndrome Market Status (2014-2019)
6.1.9 Benelux Irritable Bowel Syndrome Market Status (2014-2019)
6.2 Europe Irritable Bowel Syndrome Market Status by Manufacturers
6.3 Europe Irritable Bowel Syndrome Market Status by Type (2014-2019)
6.3.1 Europe Irritable Bowel Syndrome Sales by Type (2014-2019)
6.3.2 Europe Irritable Bowel Syndrome Revenue by Type (2014-2019)
6.4 Europe Irritable Bowel Syndrome Market Status by Downstream Industry (2014-2019)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
7.1 Asia Pacific Irritable Bowel Syndrome Market Status by Countries
7.1.1 Asia Pacific Irritable Bowel Syndrome Sales by Countries (2014-2019)
7.1.2 Asia Pacific Irritable Bowel Syndrome Revenue by Countries (2014-2019)
7.1.3 China Irritable Bowel Syndrome Market Status (2014-2019)
7.1.4 Japan Irritable Bowel Syndrome Market Status (2014-2019)
7.1.5 India Irritable Bowel Syndrome Market Status (2014-2019)
7.1.6 Southeast Asia Irritable Bowel Syndrome Market Status (2014-2019)
7.1.7 Australia Irritable Bowel Syndrome Market Status (2014-2019)
7.2 Asia Pacific Irritable Bowel Syndrome Market Status by Manufacturers
7.3 Asia Pacific Irritable Bowel Syndrome Market Status by Type (2014-2019)
7.3.1 Asia Pacific Irritable Bowel Syndrome Sales by Type (2014-2019)
7.3.2 Asia Pacific Irritable Bowel Syndrome Revenue by Type (2014-2019)
7.4 Asia Pacific Irritable Bowel Syndrome Market Status by Downstream Industry (2014-2019)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
8.1 Latin America Irritable Bowel Syndrome Market Status by Countries
8.1.1 Latin America Irritable Bowel Syndrome Sales by Countries (2014-2019)
8.1.2 Latin America Irritable Bowel Syndrome Revenue by Countries (2014-2019)
8.1.3 Brazil Irritable Bowel Syndrome Market Status (2014-2019)
8.1.4 Argentina Irritable Bowel Syndrome Market Status (2014-2019)
8.1.5 Colombia Irritable Bowel Syndrome Market Status (2014-2019)
8.2 Latin America Irritable Bowel Syndrome Market Status by Manufacturers
8.3 Latin America Irritable Bowel Syndrome Market Status by Type (2014-2019)
8.3.1 Latin America Irritable Bowel Syndrome Sales by Type (2014-2019)
8.3.2 Latin America Irritable Bowel Syndrome Revenue by Type (2014-2019)
8.4 Latin America Irritable Bowel Syndrome Market Status by Downstream Industry (2014-2019)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
9.1 Middle East and Africa Irritable Bowel Syndrome Market Status by Countries
9.1.1 Middle East and Africa Irritable Bowel Syndrome Sales by Countries (2014-2019)
9.1.2 Middle East and Africa Irritable Bowel Syndrome Revenue by Countries (2014-2019)
9.1.3 Middle East Irritable Bowel Syndrome Market Status (2014-2019)
9.1.4 Africa Irritable Bowel Syndrome Market Status (2014-2019)
9.2 Middle East and Africa Irritable Bowel Syndrome Market Status by Manufacturers
9.3 Middle East and Africa Irritable Bowel Syndrome Market Status by Type (2014-2019)
9.3.1 Middle East and Africa Irritable Bowel Syndrome Sales by Type (2014-2019)
9.3.2 Middle East and Africa Irritable Bowel Syndrome Revenue by Type (2014-2019)
9.4 Middle East and Africa Irritable Bowel Syndrome Market Status by Downstream Industry (2014-2019)
Chapter 10 Market Driving Factor Analysis of Irritable Bowel Syndrome
10.1 Global Economy Situation and Trend Overview
10.2 Irritable Bowel Syndrome Downstream Industry Situation and Trend Overview
Chapter 11 Irritable Bowel Syndrome Market Competition Status by Major Manufacturers
11.1 Production Volume of Irritable Bowel Syndrome by Major Manufacturers
11.2 Production Value of Irritable Bowel Syndrome by Major Manufacturers
11.3 Basic Information of Irritable Bowel Syndrome by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Irritable Bowel Syndrome Major Manufacturer
11.3.2 Employees and Revenue Level of Irritable Bowel Syndrome Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
Chapter 12 Irritable Bowel Syndrome Major Manufacturers Introduction and Market Data
12.1 Valeant Pharmaceuticals
12.1.1 Company profile
12.1.2 Representative Irritable Bowel Syndrome Product
12.1.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals
12.2 Allergan
12.2.1 Company profile
12.2.2 Representative Irritable Bowel Syndrome Product
12.2.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Allergan
12.3 Takeda
12.3.1 Company profile
12.3.2 Representative Irritable Bowel Syndrome Product
12.3.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Takeda
12.4 Sucampo Pharmaceuticals
12.4.1 Company profile
12.4.2 Representative Irritable Bowel Syndrome Product
12.4.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sucampo Pharmaceuticals
12.5 McNeil Consumer Healthcare
12.5.1 Company profile
12.5.2 Representative Irritable Bowel Syndrome Product
12.5.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of McNeil Consumer Healthcare
12.6 Sebela Pharmaceuticals
12.6.1 Company profile
12.6.2 Representative Irritable Bowel Syndrome Product
12.6.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sebela Pharmaceuticals
12.7 Astellas Pharmaceuticals
12.7.1 Company profile
12.7.2 Representative Irritable Bowel Syndrome Product
12.7.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Astellas Pharmaceuticals
12.8 IM HealthScience
12.8.1 Company profile
12.8.2 Representative Irritable Bowel Syndrome Product
12.8.3 Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of IM HealthScience
Chapter 13 Upstream and Downstream Market Analysis of Irritable Bowel Syndrome
13.1 Industry Chain of Irritable Bowel Syndrome
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Irritable Bowel Syndrome
14.1 Cost Structure Analysis of Irritable Bowel Syndrome
14.2 Raw Materials Cost Analysis of Irritable Bowel Syndrome
14.3 Labor Cost Analysis of Irritable Bowel Syndrome
14.4 Manufacturing Expenses Analysis of Irritable Bowel Syndrome
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference

List of Tables

Table Advantage and Disadvantage of IBS-D Drug
Table Advantage and Disadvantage of IBS-C Drug
Table Advantage and Disadvantage of Others
Table Sales Volume of Irritable Bowel Syndrome by Regions 2013-2017
Table Sales Value of Irritable Bowel Syndrome by Regions 2013-2017
Table Production Volume of Irritable Bowel Syndrome by Regions 2013-2017
Table Global Sales Volume of Irritable Bowel Syndrome by Regions 2018-2023
Table Global Sales Value of Irritable Bowel Syndrome by Regions 2018-2023
Table Global Production Volume of Irritable Bowel Syndrome by Regions 2018-2023
Table Sales Volume of Irritable Bowel Syndrome by Types 2013-2017
Table Sales Value of Irritable Bowel Syndrome by Types 2013-2017
Table Sales Volume Forecast of Irritable Bowel Syndrome by Types 2018-2023
Table Sales Value Forecast of Irritable Bowel Syndrome by Types 2018-2023
Table Sales Volume of Irritable Bowel Syndrome by Downstream Industry 2013-2017
Table Sales Volume Forecast of Irritable Bowel Syndrome by Downstream Industry 2018-2023
Table North America Irritable Bowel Syndrome Sales by Countries (2013-2017)
Table North America Irritable Bowel Syndrome Sales Share by Countries (2013-2017)
Table North America Irritable Bowel Syndrome Revenue by Countries (2013-2017)
Table North America Irritable Bowel Syndrome Revenue Market Share by Countries (2013-2017)
Table North America Irritable Bowel Syndrome Sales by Type (2013-2017)
Table North America Irritable Bowel Syndrome Sales Share by Type (2013-2017)
Table North America Irritable Bowel Syndrome Revenue by Type (2013-2017)
Table North America Irritable Bowel Syndrome Revenue Share by Type (2013-2017)
Table North America Irritable Bowel Syndrome Sales by Downstream Industry (2013-2017)
Table North America Irritable Bowel Syndrome Sales Share by Downstream Industry (2013-2017)
Table Europe Irritable Bowel Syndrome Sales by Countries (2013-2017)
Table Europe Irritable Bowel Syndrome Sales Share by Countries (2013-2017)
Table Europe Irritable Bowel Syndrome Revenue by Countries (2013-2017)
Table Europe Irritable Bowel Syndrome Revenue Market Share by Countries (2013-2017)
Table Europe Irritable Bowel Syndrome Sales by Type (2013-2017)
Table Europe Irritable Bowel Syndrome Sales Share by Type (2013-2017)
Table Europe Irritable Bowel Syndrome Revenue by Type (2013-2017)
Table Europe Irritable Bowel Syndrome Revenue Share by Type (2013-2017)
Table Europe Irritable Bowel Syndrome Sales by Downstream Industry (2013-2017)
Table Europe Irritable Bowel Syndrome Sales Share by Downstream Industry (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales by Countries (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales Share by Countries (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Revenue by Countries (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Revenue Market Share by Countries (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales by Type (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales Share by Type (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Revenue by Type (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Revenue Share by Type (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales by Downstream Industry (2013-2017)
Table Asia Pacific Irritable Bowel Syndrome Sales Share by Downstream Industry (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales by Countries (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales Share by Countries (2013-2017)
Table Latin America Irritable Bowel Syndrome Revenue by Countries (2013-2017)
Table Latin America Irritable Bowel Syndrome Revenue Market Share by Countries (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales by Type (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales Share by Type (2013-2017)
Table Latin America Irritable Bowel Syndrome Revenue by Type (2013-2017)
Table Latin America Irritable Bowel Syndrome Revenue Share by Type (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales by Downstream Industry (2013-2017)
Table Latin America Irritable Bowel Syndrome Sales Share by Downstream Industry (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales by Regions (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales Share by Regions (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Revenue by Regions (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Revenue Market Share by Regions (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales by Type (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales Share by Type (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Revenue by Type (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Revenue Share by Type (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales by Downstream Industry (2013-2017)
Table Middle East and Africa Irritable Bowel Syndrome Sales Share by Downstream Industry (2013-2017)
Table Production Volume of Irritable Bowel Syndrome by Major Manufacturers 2013-2017
Table Production Value of Irritable Bowel Syndrome by Major Manufacturers 2013-2017
Table Headquarters Location and Established Time of Irritable Bowel Syndrome Major Manufacturer
Table Employees and Revenue Level of Irritable Bowel Syndrome Major Manufacturer
Table Representative Irritable Bowel Syndrome Product One of Valeant Pharmaceuticals
Table Representative Irritable Bowel Syndrome Product Two of Valeant Pharmaceuticals
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals 2013-2017
Table Representative Irritable Bowel Syndrome Product One of Allergan
Table Representative Irritable Bowel Syndrome Product Two of Allergan
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Allergan 2013-2017
Table Representative Irritable Bowel Syndrome Product One of Takeda
Table Representative Irritable Bowel Syndrome Product Two of Takeda
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Takeda 2013-2017
Table Representative Irritable Bowel Syndrome Product One of Sucampo Pharmaceuticals
Table Representative Irritable Bowel Syndrome Product Two of Sucampo Pharmaceuticals
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sucampo Pharmaceuticals 2013-2017
Table Representative Irritable Bowel Syndrome Product One of McNeil Consumer Healthcare
Table Representative Irritable Bowel Syndrome Product Two of McNeil Consumer Healthcare
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of McNeil Consumer Healthcare 2013-2017
Table Representative Irritable Bowel Syndrome Product One of Sebela Pharmaceuticals
Table Representative Irritable Bowel Syndrome Product Two of Sebela Pharmaceuticals
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Sebela Pharmaceuticals 2013-2017
Table Representative Irritable Bowel Syndrome Product One of Astellas Pharmaceuticals
Table Representative Irritable Bowel Syndrome Product Two of Astellas Pharmaceuticals
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of Astellas Pharmaceuticals 2013-2017
Table Representative Irritable Bowel Syndrome Product One of IM HealthScience
Table Representative Irritable Bowel Syndrome Product Two of IM HealthScience
Table Irritable Bowel Syndrome Sales, Revenue, Price and Gross Margin of IM HealthScience 2013-2017

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.